Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses. Naderi N, Rahimzadeh M. Virology 2022;566:106-113.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Naderi N, Rahimzadeh M. Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses. Virology 2022;566:106-113.
PMID: 34896901